iRadimed Corporation (IRMD) Social Stream
IRADIMED CORP (IRMD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering IRADIMED CORP.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued February 3, 2023
The Trend in the Analyst Price Target
IRMD's average price target has moved up $19.5 over the prior 23 months.
IRMD reports an average of 20.55% for its upside potential over the past 40 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
IRMD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
IRMD's average broker recommendation rating improved by 0 over the prior 39 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- IRADIMED CORP's number of analysts covering the stock is greater than 9.21% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, IRADIMED CORP's variance in analysts' estimates is lower than 78.85% of them.
- In the context of stocks in the small market cap category, IRADIMED CORP's average analyst price target is greater than 807.38% of them.
- In the context of stocks in the small market cap category, IRADIMED CORP's upside potential (average analyst target price relative to current price) is greater than 130.19% of them.
What is the outlook for IRMD? Use POWR Ratings for clearer insight into price direction.